UPDATE : Friday, June 5, 2020
New osteoporosis therapy causes curiosity about drug price
Ten years have passed since Amgen’s “Prolia,” the so-called first biologica...
by Park Gi-taek  |  2017-08-07 14:42
Handok expands gene testing analysis to children
Handok has expanded its genome testing service to children, the company sai...
by Marian Chu  |  2017-08-07 11:06
Clearer standards for relief of harms from drugs’ side effects
The standards for medical products excluded from the application for the re...
by Lee Hye-seon  |  2017-08-04 18:30
Cosmetics firm acquires external preparations maker
Cosmetics company Tonymoly has bought a 47.6-percent stake of Tai Guk Pharm...
by Lee Hye-seon  |  2017-08-03 16:18
Yungjin’s new drug completes phase 2a clinical trial in US
Yungjin Pharmaceutical has secured the safety of “YPL-001,” a new drug to t...
by Lee Hye-seon  |  2017-08-03 15:42
Phase 3 clinical trials for new schizophrenia drug
Bukwang Pharmaceutical will enter into phase 3 clinical trials of Lurasidon...
by Lee Hye-seon  |  2017-08-03 14:53
FDA approves Imbruvica treat chronic GVHD
The U.S. Food and Drug Administration (FDA) Wednesday expanded the approval...
by Constance Williams  |  2017-08-03 10:32
Pharmaceuticals stage fierce competition over composite drugs
Korean pharmaceutical companies are focusing their attention on the develop...
by Lee Hye-seon  |  2017-08-02 17:01
Celgene’s leukemia drug wins FDA approval
The U.S. Food and Drug Administration Tuesday approved Idhifa (compound: en...
by Constance Williams  |  2017-08-02 10:31
MSD gets approval to expand Januvia label
MSD Korea said Tuesday that its Januvia (ingredient name: Citigliptin), Jan...
by Constance Williams  |  2017-08-01 17:37
Regulators to add liver damage risks to antiobestic drug
Antiobestic drug Contrav ER Tab. (compound: naltrexon/bupropion), imported ...
by Lee Hye-seon  |  2017-08-01 17:21
LG’s development of composite drug gains momentum
The development of the ‘Gemigliptin+Rosuvastatin’ complex developed by LG C...
by Lee Hye-seon  |  2017-08-01 15:24
Lilly’s Lartruvo to hit domestic market
Lilly Korea said Tuesday it would release an advanced soft tissue sarcoma t...
by Constance Williams  |  2017-08-01 14:03
Takeda gets approval for multiple myeloma drug
Takeda Pharmaceuticals Korea한국다케다제약 said its Ninlarco (ingredient name: ixa...
by Constance Williams  |  2017-08-01 10:47
Stress management crucial for operation-room nurses
A bill has been proposed to prohibit overtime work by doctors and nurses to...
by Nam Doo-hyun  |  2017-07-31 17:20
248 drugs taken off the market for low profitability
The sales of 248 medicines were stopped because of low profitability betwee...
by Kwak Sung-sun  |  2017-07-28 16:39
Chinese control of biological resources alerts Korean drugmakers
The Chinese government will likely implement a decree this year, which forc...
by Nam Doo-hyun  |  2017-07-28 14:14
Domestic pharmaceuticals’ Q2 earnings surprise investors
Domestic pharmaceutical companies’ coffers are overflowing with cash, thank...
by Constance Williams  |  2017-07-28 12:05
Green Cross’ 2Q operating profit jumps 43.6%
Green Cross announced Wednesday that its operating profit in the second qua...
by Lee Hye-seon  |  2017-07-27 16:35
Celltrion show record-high performances in Q2
Celltrion recorded sales of 246.1 billion won ($221 million), and operating...
by Nam Doo-hyun  |  2017-07-27 15:51
Back to Top